Page 2 - Best Immunotherapy with Keytruda (Pembolizumab) doctors: TOP 63 doctors

Dr. Ozadli specializes in lung and gastrointestinal cancers, with extensive training at Ankara Oncology Hospital.

• Medical oncology specialist with focus on immunotherapy treatments
• Experience at Ankara Oncology Hospital – a leading center for cancer care
• Trained at Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
• Special interest in lung, esophageal, and gastric cancers

Head of Neurooncology Clinic at Sourasky Medical Center (Ichilov) – specializes in advanced cancer treatments.

• Leads a dedicated team for neurooncology cases
• Focuses on innovative therapies like immunotherapy
• Works at one of Israel's top medical centers

Dr. Fredi Aviv brings 34 years of experience of oncohematology expertise to immunotherapy treatments at Sourasky Medical Center (Ichilov Clinic).

• Specializes in hematologic oncology and immunotherapy
• Practices at a leading medical center in Israel
• Extensive experience with cutting-edge cancer treatments

Director of oncology hospitalization at Tel Aviv Medical Center, Ichilov – Dr. Stepfansky brings extensive clinical and research expertise to immunotherapy cases.

• Over 26 years of experience of experience in oncology and internal medicine
• Actively involved in Phase I-III clinical trials for new cancer treatments
• Specialized training in oncology from Tel Aviv Medical Center, Ichilov
• Holds multiple research roles in cutting-edge immunotherapy studies

Director of children's hematology oncology at Sourasky Medical Center, specializing in bone cancer (sarcoma) and blood disorders.

• Senior pediatrician at Children's Hospital 'Dana'
• Specializes in pediatric hematology and oncology
• Member of the Israeli association ISPHO
• Studied oncology bone and soft tissue in Italy's Rizzoli Orthopaedic Institute

Dr. Alemdar specializes in immunotherapy with Keytruda at Medical Park Antalya Hospital Complex, bringing extensive experience in medical oncology.

• Board-certified in medical oncology since 2018
• Over 20 years of experience of experience in internal medicine and oncology
• Worked at Akdeniz University Hospital, a leading medical institution

Dr. Yair specializes in hematology with a focus on chronic lymphocytic leukemia – recognized with multiple awards for his research and clinical excellence.

• Recipient of the Klitzberg Oncology Award and other prestigious honors
• Member of both Israeli and American Hematology Associations
• Trained at top medical centers in Israel
• Published extensively in hematology research

Dr. Sonnenblick Amir specializes in targeted therapies for breast cancer, including immunotherapy with Keytruda (Pembolizumab). He's recognized with multiple awards for his contributions to oncology research.

• ESMO Breast Cancer Translational and Clinical Research Fellowship at Jules Bordet Institute
• Over 30 presentations at national and international scientific meetings
• Recipient of the ESMO Breast Cancer Translational Research Award
• Member of European Society of Medical Oncology (ESMO)

Dr. Tahsin Ozatli specializes in breast, lung, and gastrointestinal cancers, bringing focused expertise to immunotherapy treatments.

• Associate Professor since 2016
• Experienced across multiple oncology departments in Turkey
• Graduated from Selcuk University's Faculty of Medicine

Specializes in immunotherapy for tumor diseases, with expertise in Keytruda (Pembrolizumab). Recognized for molecular biology research in cancer treatment.

• Chief Physician at certified interdisciplinary cancer center BKZ Solingen
• Active member of American Association for Cancer Research
• Specializes in chemotherapy, immunotherapy, and targeted therapies
• Qualified specialist in genetics
• Works closely with leading haematologists

Dr. Auala Hubert brings 36 years of experience of expertise in oncology and radiotherapy at Hadassah Medical Center, specializing in immunotherapy.

• Heads the Gastrointestinal Cancer Center – deep expertise in complex cases
• Trained at Hadassah University Hospital – one of Israel's leading oncology centers
• Active member of multiple cancer research and treatment committees

Assoc. Prof. Nail Paksoy specializes in immunotherapy at Medipol Bahçelievler Hospital, with extensive experience in clinical trials involving Keytruda.

• ESMO Board Certified in Medical Oncology
• Subinvestigator in multiple international immunotherapy trials
• Published research on advanced cancer treatments
• Dual fellowship in Medical Oncology and Allergy-Immunology

Dr. Weidmann heads the Hematology sector at Nordwest Clinic with 36 years of experience in blood disorder treatment.

• Specializes in non-Hodgkin lymphoma cases
• Professor with extensive academic credentials
• Works at Nordwest Clinic – a leading hematology center

Dr. Ozden brings over 27 years of experience of medical oncology experience to his role at VM Medical Park Pendik Hospital.

• Specialized in Medical Oncology at Kocaeli University
• Graduated from Istanbul University's English Medical Program
• Worked across multiple hospitals specializing in internal medicine

Professor Cicin specializes in immunotherapy at İstinye University Liv Hospital Topkapı, with over 29 years of experience in medical oncology.

• Fellowship-trained in medical oncology at Trakya University
• Professor at Trakya University Faculty of Medicine
• Extensive experience in treating cancer patients with immunotherapy

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.